ReviewTranslational oncology2022
HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases.
Geetha Shanmugam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
94 papers cite itlatest 60 shown
this papercites it